In view of the above reports, targeting STAT3 has the potential to be an important approach for the treatment of depression; we found that silencing miR-124-3p promoted the expression of STAT3 in neuronal CORT damage experiments, and dual-luciferase experiments confirmed that miR-124-3p and STAT3 have targeted regulation. Here, STAT3 is linked to depressive symptom measurement.